BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 38557758)

  • 21. Impact of cancer surgery slowdowns on patient survival during the COVID-19 pandemic: a microsimulation modelling study.
    Parmar A; Eskander A; Sander B; Naimark D; Irish JC; Chan KKW
    CMAJ; 2022 Mar; 194(11):E408-E414. PubMed ID: 35314440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21.
    COVID-19 Excess Mortality Collaborators
    Lancet; 2022 Apr; 399(10334):1513-1536. PubMed ID: 35279232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends in colon and rectal cancer mortality in Australia from 1972 to 2015 and associated projections to 2040.
    Luo Q; Lew JB; Steinberg J; Worthington J; Yu XQ; Caruana M; Soerjomataram I; Bray F; Lawrance S; Arcorace M; O'Connell DL; Canfell K; Feletto E
    Sci Rep; 2022 Mar; 12(1):3994. PubMed ID: 35256697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How Were Wait Times for Priority Procedures in Canada Impacted during the First Six Months of the COVID-19 Pandemic?
    Reason B; Pichora E; Johnson T
    Healthc Q; 2022 Jan; 24(4):11-15. PubMed ID: 35216643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prioritisation of colonoscopy services in colorectal cancer screening programmes to minimise impact of COVID-19 pandemic on predicted cancer burden: A comparative modelling study.
    van Wifferen F; de Jonge L; Worthington J; Greuter MJE; Lew JB; Nadeau C; van den Puttelaar R; Feletto E; Yong JHE; Lansdorp-Vogelaar I; Canfell K; Coupé VMH;
    J Med Screen; 2022 Jun; 29(2):72-83. PubMed ID: 35100894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of cumulative colorectal cancer screening delays: A simulation study.
    Rutter CM; Inadomi JM; Maerzluft CE
    J Med Screen; 2022 Jun; 29(2):92-98. PubMed ID: 34894841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicted long-term impact of COVID-19 pandemic-related care delays on cancer mortality in Canada.
    Malagón T; Yong JHE; Tope P; Miller WH; Franco EL;
    Int J Cancer; 2022 Apr; 150(8):1244-1254. PubMed ID: 34843106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measuring the impact of the COVID-19 pandemic on organized cancer screening and diagnostic follow-up care in Ontario, Canada: A provincial, population-based study.
    Walker MJ; Meggetto O; Gao J; Espino-Hernández G; Jembere N; Bravo CA; Rey M; Aslam U; Sheppard AJ; Lofters AK; Tammemägi MC; Tinmouth J; Kupets R; Chiarelli AM; Rabeneck L
    Prev Med; 2021 Oct; 151():106586. PubMed ID: 34217413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Impact of the COVID-19 Pandemic on Demand for Emergency Ambulances in Victoria, Australia.
    Andrew E; Nehme Z; Stephenson M; Walker T; Smith K
    Prehosp Emerg Care; 2021 Jul; ():1-7. PubMed ID: 34152925
    [No Abstract]   [Full Text] [Related]  

  • 30. Health systems resilience in managing the COVID-19 pandemic: lessons from 28 countries.
    Haldane V; De Foo C; Abdalla SM; Jung AS; Tan M; Wu S; Chua A; Verma M; Shrestha P; Singh S; Perez T; Tan SM; Bartos M; Mabuchi S; Bonk M; McNab C; Werner GK; Panjabi R; Nordström A; Legido-Quigley H
    Nat Med; 2021 Jun; 27(6):964-980. PubMed ID: 34002090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measures of longitudinal adherence to fecal-based colorectal cancer screening: Literature review and recommended approaches.
    Doria-Rose VP; Lansdorp-Vogelaar I; McCarthy S; Puricelli-Perin DM; Butera V; Segnan N; Taplin SH; Senore C
    Int J Cancer; 2021 Jul; 149(2):316-326. PubMed ID: 33811643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer Screening in the Coronavirus Pandemic Era: Adjusting to a New Situation.
    Basu P; Alhomoud S; Taghavi K; Carvalho AL; Lucas E; Baussano I
    JCO Glob Oncol; 2021 Mar; 7():416-424. PubMed ID: 33784177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Access to Cancer Surgery in a Universal Health Care System During the COVID-19 Pandemic.
    Eskander A; Li Q; Hallet J; Coburn N; Hanna TP; Irish J; Sutradhar R
    JAMA Netw Open; 2021 Mar; 4(3):e211104. PubMed ID: 33704472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A global panel database of pandemic policies (Oxford COVID-19 Government Response Tracker).
    Hale T; Angrist N; Goldszmidt R; Kira B; Petherick A; Phillips T; Webster S; Cameron-Blake E; Hallas L; Majumdar S; Tatlow H
    Nat Hum Behav; 2021 Apr; 5(4):529-538. PubMed ID: 33686204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study.
    de Jonge L; Worthington J; van Wifferen F; Iragorri N; Peterse EFP; Lew JB; Greuter MJE; Smith HA; Feletto E; Yong JHE; Canfell K; Coupé VMH; Lansdorp-Vogelaar I;
    Lancet Gastroenterol Hepatol; 2021 Apr; 6(4):304-314. PubMed ID: 33548185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of episodic screening interruption: COVID-19 and population-based cancer screening in Canada.
    Yong JH; Mainprize JG; Yaffe MJ; Ruan Y; Poirier AE; Coldman A; Nadeau C; Iragorri N; Hilsden RJ; Brenner DR
    J Med Screen; 2021 Jun; 28(2):100-107. PubMed ID: 33241760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mortality due to cancer treatment delay: systematic review and meta-analysis.
    Hanna TP; King WD; Thibodeau S; Jalink M; Paulin GA; Harvey-Jones E; O'Sullivan DE; Booth CM; Sullivan R; Aggarwal A
    BMJ; 2020 Nov; 371():m4087. PubMed ID: 33148535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prioritisation by FIT to mitigate the impact of delays in the 2-week wait colorectal cancer referral pathway during the COVID-19 pandemic: a UK modelling study.
    Loveday C; Sud A; Jones ME; Broggio J; Scott S; Gronthound F; Torr B; Garrett A; Nicol DL; Jhanji S; Boyce SA; Williams M; Barry C; Riboli E; Kipps E; McFerran E; Muller DC; Lyratzopoulos G; Lawler M; Abulafi M; Houlston RS; Turnbull C
    Gut; 2021 Jun; 70(6):1053-1060. PubMed ID: 32855306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluating health benefits and cost-effectiveness of a mass-media campaign for improving participation in the National Bowel Cancer Screening Program in Australia.
    Worthington J; Feletto E; Lew JB; Broun K; Durkin S; Wakefield M; Grogan P; Harper T; Canfell K
    Public Health; 2020 Feb; 179():90-99. PubMed ID: 31760206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of a mass media campaign on participation rates in a National Bowel Cancer Screening Program: a field experiment.
    Durkin SJ; Broun K; Spittal MJ; Wakefield MA
    BMJ Open; 2019 Jan; 9(1):e024267. PubMed ID: 30813110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.